282.55MUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00289Y1073
CUSIP
00431M308
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.97
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.55
Wall Street Target Price
20.07
EPS Estimate Current Year
-1.07
EPS Estimate Next Year
0.01
EPS Estimate Current Quarter
-0.3433
EPS Estimate Next Quarter
-0.3833
Most Recent Quarter
-
Revenue TTM
0
Gross Profit TTM
-34,360,000
EBITDA
-62,207,000
Profit Margin
0.00%
Return On Assets TTM
-46.41%
Return On Equity TTM
-216.57%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
-100.00%
Diluted Eps TTM
-1.55
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
37.7567
Price Book MRQ
6.4171
Enterprise Value Revenue
53
Enterprise Value EBITDA
0
161.19
10.03%595.00
2.04%88.72
1.94%77.61
1.25%228.38
1.19%285.20
0.71%435.01
0.25%561.16
0.07%562.00
0.00%168.65
-1.23%